TMC eyes 30% revenue from fertility business

(From left) TMC Women’s Specialist Holdings Sdn Bhd, IVF Technologies Sdn Bhd, Thomson TCM Sdn Bhd, TMC Biotech Sdn Bhd, and TMC Care Sdn Bhd CEO Irene Kwan Yee Man, TMC Life Sciences Bhd executive director Barry Kan Kheong Ng, chairman Professor Emeritus Datuk Dr Khalid Abdul Kadir, group CEO Wan Nadiah Wan Mohd Abdullah Yaakob and group CFO Jimmy Wong Yu Chee.

PETALING JAYA: TMC Life Sciences Bhd aims to grow its fertility business to contribute 30% to total group revenue for the financial year ending June 30,2021 (FY21), from the current 17%.

This will be partly driven by the group’s new fertility centre in Puchong, which is expected to commence operations this May.